- Home
- / Antag Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Antag Therapeutics financials data including stock price, CreditSafe score, income statement, and balance sheet.
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| DKK | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Gross profit | (7.9M) | (10.9M) | (13.1M) |
| General and administrative expense | 3.5M | 3.7M | 2.7M |
| Operating expense total | 3.5M | 3.7M | 2.7M |
| Depreciation and amortization | 13.0K | 26.6K | 33.8K |
| EBIT | (11.4M) | (14.6M) | (15.8M) |
| Pre tax profit | (11.8M) | (15.0M) | (17.5M) |
| Income tax expense | 2.6M | (2.6M) | 2.6M |
| Net Income | (9.2M) | (12.4M) | (14.9M) |